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134 S. Barral et al.enrichment of neuronal precursors based on PSA-NCAM expression represents a general and straightforward approach
to narrow cellular heterogeneity during neuronal differentiation of pluripotent cells.
© 2012 Elsevier B.V. All rights reserved.Introduction Cremer, 2001; Rousselot, et al., 1995). In general, PSA-NCAMPluripotent stem cells hold the potential to generate all cell
types in culture, but the development of methods which
control differentiation to induce generation of one cell type
over another has proved challenging. The differentiation
ofmouse and human pluripotent stem cells into specific neural
subpopulations has been achieved using determined extra-
cellular environments, specific signaling factors, small mole-
cules, co-culture systems, or transgenic modifications (Chung
et al., 2002; Friling et al., 2009; Kawasaki et al., 2000; Lee
et al., 2000; Martinat et al., 2006; Okabe et al., 1996; Tropepe
et al., 2001; Wichterle, et al., 2002; Ying, et al., 2003).
However, despite the general progress in differentiation
strategies, several aspects are still insufficiently understood,
especially when aiming at pluripotent cell-derived neurons for
regenerative approaches. For example, lack of synchronicity
and purity of the target cell population represent two major
limitations. Target cells should fit into a specific develop-
mental window since implantation of pre-differentiated and
proliferative cells can give rise to slow-growing tumors (Roy
et al., 2006), while cells too advanced in their differentiation
may be unable of functional integration (MacLaren et al.,
2006). Moreover, the presence of undifferentiated pluripotent
cells must be avoided to prevent teratoma formation upon
in vivo injection (Bjorklund et al., 2002; Thomson et al.,
1998).
Cell sorting strategies have been suggested as one way to
address these issues (Sharp and Keirstead, 2009). Accordingly,
specific cell surface markers and the respective antibodies
have been reported for undifferentiated pluripotent cells
as well as for differentiated neural cells, both in humans and
rodents (Golebiewska, et al., 2009; Pruszak, et al., 2009;
Pruszak, et al., 2007). In addition, several flow cytometer and
magnetic bead based protocols using a combinatorial surface
antigen code have been applied to enrich ES-derived neural
precursors (Chung et al., 2011; Pruszak, et al., 2009, 2007;
Yuan et al., 2011). Depending on the target cell number and
the need for a closed, sterile procedure, magnetic sorting
rather than flow sorting has been reported to allow for a faster
separation and gentler handling of cells, and operations under
sterile conditions (Bosio et al., 2009; Pruszak, et al., 2007).
The polysialylated acid (PSA) was described as a major
macromolecular component of the vertebrate brain (Finne,
1982) being attached exclusively to the cell surface glycopro-
tein neural cell adhesion molecule (NCAM) (Cremer et al.,
1994; Finne, et al., 1983). The neuroanatomical distribution of
PSA-NCAM differs between the developing and adult nervous
system. PSA-NCAM expression peaks in the late embryonic and
post-natal developing nervous system (Finne, 1982) and is
considered a marker for immature neural precursors (Nguyen,
et al., 2003). In the adult brain, NCAM displays low levels
of polysialylation (Angata and Fukuda, 2003) with the excep-
tion of areas that show ongoing neurogenesis, such as the
subventricular zone–rostral–migratory stream–olfactory bulb
system and the hippocampal dentate gyrus (Durbec andis considered a promoter of neural plasticity, allowing migra-
tion and facilitating axonal pathfinding, synaptogenesis
(El Maarouf and Rutishauser, 2003; Kiss and Rougon, 1997)
and synaptic plasticity (Cremer et al., 1998; Muller et al.,
1996). The level of PSA-NCAM has been shown to increase in
chronic stress conditions (Pham, et al., 2003) and lesion
models as ischemia, epilepsy, brain trauma, and transected/
crushed peripheral nerves (Bonfanti et al., 1996; Franz, et al.,
2005; Rutishauser and Landmesser, 1996). Based on these
properties it has been proposed that PSA-NCAM expressing
cells hold potential for promoting brain repair (El Maarouf,
et al., 2006; Franz, et al., 2005; Nguyen, et al., 2003) and
neuroprotection (Duveau, et al., 2007).
In this study we analyzed PSA-NCAM expression during
neuronal differentiation of pluripotent mESC and developed
a method for isolation of the PSA-NCAM positive precursor
population by immunomagnetic sorting. Based thereon
we investigated if PSA-NCAM-mediated enrichment is suited
to decrease heterogeneity of in vitro generated neuronal
precursors. We then characterized the differentiation poten-
tial of the PSA-NCAM-enriched neural precursors in vitro and
observed an increase in the number of neuronal cells at the
end of the differentiation process. In order to analyze if
PSA-NCAM enriched cells could behave as in vivo neuroblast,
we stereotactically injected the sorted population into
the forebrain of adult mice. Here, PSA-NCAM+ mESC derived
neuronal precursors showed efficient migration and predom-
inant differentiation into NeuN positive neurons. In summary
we showed that a straightforward in vitro enrichment of ES
cell derived neuronal precursor cells can be used to promote




Two month old C57BL/6 mice were purchased from Charles
River and used as host animals. Animals were housed under
standard conditions with access to water and food ad libitum on
a normal 12 h light/dark cycle. Experiments were performed in
accordancewith the principles for laboratory animals published
by the French Ethical Committee.
Mouse ES cell culture and in vitro differentiation
Actin-eGFP C57BL/6 mESCs were propagated on Mitomycin-C
(Sigma-Aldrich, Steinheim, Germany, http://www.
sigmaaldrich.com)-treated mouse fibroblasts in DMEM
(Miltenyi Biotec, Bergisch Gladbach, Germany, http://www.
miltenyibiotec.com) supplemented with 1 mM nonessential
amino acids (PAA, Cölbe, Germany, http://www.paa.com/),
1× Na Pyruvate (PAA), 2 mM L-Glutamine (PAA) 0.1 mM
b-Mercaptoethanol, 1% Penicillin Streptomycin (PAA), 10% FCS
Figure 1 In vitro differentiation and immunomagnetic enrichment of mESC derived PSA-NCAM+ neural precursors. (A) Schematic
representation of neural differentiation. (B) Flow cytometric analysis of PSA-NCAM expression during neural differentiation. (C, E)
Immunofluorescence microscopy of in vitro derived PSA-NCAM+ precursors (red) before (C) and after magnetic separation (E), nuclei
stained with DAPI (blue). (D) Intensity distribution of PSA-NCAM+ cells before (Ori. Fr.) and after (Pos. Fr.) magnetic cell sorting. Scale
bar=50 μm. Abbreviations: mESC, mouse embryonic stem cells; EBs, embryoid bodies; ITSFn, insulin transferrin selenium fibronectin;
bFGF, basic fibroblast growth factor; AA, ascorbic acid; PSA-NCAM, polysialylated neural cell adhesion molecule; FCS, forward
scatter; Ori. Fr., original fraction; Pos. Fr., positive fraction.
Efficient neuronal differentiation after purification of mESC derived neuronal precursors 135(PAA) and 0.01% LIF (Miltenyi Biotec) (step 1). Cells were
split every two days and plated at a concentration of
25,000/cm2. Before embryoid bodies (EBs) differentiation
(step 2), cells were harvested with 0.05% Trypsin (Sigma),
subjected to feeder depletion with Feeder Removal
MicroBeads Kit (Miltenyi Biotec) and then plated on non-
adherent bacterial dishes for four days in LIF free EB medium
containing 5% of knockout serum replacement (Invitrogen,
Frederick, MD, http://www.invitrogen.com) and 5% FCS
(PAA). EBs were then plated onto adhesive tissue culture
surface. After 24 h in culture, selection of neural progenitor
cells was initiated in serum-free 1× ITS liquid media
supplements (Sigma-Aldrich) plus 5 mg/ml Fn (Biopure,
Bubendorf, Switzerland, http://www.biopur.com/index.
php) supplemented with DMEM medium (ITSFn, step 3).
After 6 days (6 d) of selection, cells were harvested with
AccuMax (PAA), plated on polyornithine (Sigma-Aldrich) and
laminin (Sigma-Aldrich) coated 24 well plates and cultivat-
ed for 5 d (step 4) in MACS Neuro Medium (Miltenyi)
supplemented with 1× N2 supplement (PAA), 1 mM nones-
sential amino acids, 2 mM L-Glutamine, 1% Penicillin Strepto-
mycin, 1 mg/ml laminin, and 10 ng/ml bFGF (Miltenyi). For
neuronal differentiation (step 5) bFGF was removed to induce
differentiation, N2 supplement was substituted with 1× B27
(PAA) supplement and 200 mM ascorbic acid was added. Cells
were cultivated in neuronal differentiation medium for 7 d.Flow cytometric analysis
Single cell suspensions obtained at different steps of the
neuronal differentiation protocol were stained with anti-PSA-
NCAM–APC antibody (Miltenyi Biotec) for flow cytometric
analysis. 1×106 cells were incubated 10 min at 4 °C with the
conjugated antibody.
Cell debris and dead cells (identified by propidium-iodide)
were excluded from the analysis. Data was acquired on a
MACSQuant Analyzer (Miltenyi Biotec). PSA-NCAM positivity was
determined according to negative controls where no primary
antibody was used and by comparing to undifferentiated
Actin-eGFP C57BL/6 mESCs which do not express PSA-NCAM.
Magnetic labeling and cell isolation
Cell suspensions containing approximately 3×106 cells were
first labeled with anti-PSA-NCAM antibody conjugated to APC
fluorochrome (Miltenyi Biotec). Then magnetic MicroBeads
coupled to anti-APC antibody were applied. Cells were re-
suspended in mESC medium and the cell suspension was
loaded onto an MS-column (Miltenyi Biotec), which was placed
in the magnetic field of a MACS Separator. The column was
rinsed three times with 0.5 ml of medium. Magnetically
isolated PSA-NCAM positive cells were retained in the column
and eluted as the positively selected cell fraction after
136 S. Barral et al.removing the column from the magnet. Immunomagnetic
removal of dead cells prior to enrichment with anti-PSA-NCAM
was performed using the Dead Cell Removal Kit (Miltenyi
Biotec).
Isolated in vitro derived PSA-NCAM positive cells were
seeded on polyornithine and laminin coated 24-well plates
and further differentiated into neuronal lineage as describe
above for in vitro analysis or were collected in medium at a
concentration of 50,000/ml and used for transplantation.
Immunocytochemistry and statistical analysis
For immunofluorescence staining, cells were fixed in 4%
paraformaldehyde (Sigma-Aldrich-Aldrich) for 10 min,
rinsed with PBS, and then incubated with blocking buffer
(PBS, 4% bovine serum albumin) with or without 0.1% Triton
(for intracellular and surface markers respectively) for
30 min. Cells were then incubated 1 h at room temperatureFigure 2 PSA-NCAM enrichment improves in vitro neuronal diffe
4 (day 16) of unsorted control population (upper panels) versus
for (A, E) nestin (red), (B, F) PSA-NCAM (red), (C, G) Oct4 (red),
Immunocytochemistry at step 5 (differentiation day 23) of unsorte
population (lower panels). Cells stained for (I, N) TUJ1 (red), (J, O) M
(red). Nuclei stained with DAPI (blue). (S, T) Quantification of
experiments): ***Pb0.0001; **Pb0.01. Scale bar=100 μm (upper),
cell adhesion molecule; Oct4, octamer-binding transcription factor 4
decarboxylase 67; GFAP glial fibrillary acidic protein; Olig2, oligodewith the primary antibodies diluted in blocking buffer
solution. The following primary antibodies were used:
mouse anti-nestin (1:200, Santa Cruz Biotechnology, Santa
Cruz, CA, U.S.A., http://www.scbt.com/), mouse anti-PSA-
NCAM (1:500, Miltenyi Biotec), mouse anti-Oct4 (1:50, Santa
Cruz Biotechnology), mouse anti-Ki67 (1:100, BD Pharmingen,
Heidelberg, Germany, http://www.bdbiosciences.com/eu/
index.jsp), mouse anti-TUJ1 (1:500, Covance, Princeton,
New Jersey, http://www.covance.com/), mouse anti-MAP2
(1:200, Millipore, Billerica, MA, U.S.A., http://www.millipore.
com/), mouse anti-GAD67 (1:1000, Millipore), mouse anti-
NeuN (1:100, Millipore), mouse anti-GFAP (1:500, Millipore),
rabbit anti-Olig2 (1:500, Millipore), mouse anti-synaptophysin
(1:200, Sigma-Aldrich-Aldrich), and rabbit anti-VGlut-1 (1:500,
Synaptic Systems, Göttingen, Germany, http://www.sysy.
com/). After additional rinsing with PBS, samples were incu-
bated with fluorescent-labeled secondary antibody Alexa 594
anti-mouse-IgG and IgM (1:400, Invitrogen) in blocking solutionrentiation. (A–H) Immunocytochemistry at differentiation step
PSA-NCAM enriched population (lower panels). Cells stained
and (D, H) Ki67 (red). Nuclei stained with DAPI (blue). (I–R)
d control population (upper panels) versus PSA-NCAM enriched
AP2 (red), (K, P) GAD67 (red), (L, Q) GFAP (red), and (M, R) Olig2
the data presented in A–R; mean±S.E.M., n=4 (independent
50 μm (lower). Abbreviations: PSA-NCAM, polysialylated neural
; MAP2, microtubule-associated protein 2; GAD67 glutamic acid
ndrocyte transcription factor 2; nd, not detectable.
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PBS, DAPI was used for counterstaining. Immunocytochemical
control consisted in omission of the primary antibodies.
Images were acquired using Nikon Eclipse TS 100 fluores-
cence microscope. Four independent control vs enriched
experiments were considered and for each staining up to 6–8
images were acquired randomly and 750 nuclei were counted.
For statistical analysis we used the Prism software and
performed two-tailed unpaired t-test, error bars represent
the SD.
Transplantation and immunohistofluorescence
Neural progenitors-mESC-derived were harvested with
AccuMax after 6 d selection in serum free ITSFn supplemented
medium. Cells were then processed for PSA-NCAM enrichment
(see above). The positive fraction as well as the unsorted
population were resuspended in medium at a concentration
of 50,000 cells/μl. 1 μl was injected into forebrain of C57BL/6
(n=15 for each condition) at the level of the RMS (from the
bregma: 2.5 mm anterior, 0.9 mm lateral and 2.4 mm deep)
using a Kopf apparatus and a 2 μl Hamilton syringe. After 10 or
40 days post-grafting (dpg), the animals were perfused
intracardially with 4% paraformaldehyde solution in phosphate
buffer (PB). Brains were dissected out, post-fixed for 24 h
and serial sagittal or coronal sections (50 μm) were obtained
with a vibratome (Microm, Walldorf, Germany, http://www.
microm-online.com/). Free-floating sections were then incu-
bated for 1 h at room temperature in 3% BSA/PB and after-
wards incubated overnight at 4 °C in fresh blocking solution
containing a mixture of chicken or mouse antiGFP (1:500,
Aves labs, Tigard, Oregon, USA, http://www.aveslab.com/,Figure 3 Gene expression profile of neuronal differentiated PSA-N
PSA-NCAM enriched population relative to control population at step
23). (C) Compressed heatmap of upregulated genes in PSA-NCAM e
synapse; dark blue — nervous system development; magenta — transm
triplicates of control and PSA-NCAM enriched population at step 4 aand Millipore respectively) antibody and chicken anti-nestin
(1:200, Aves labs), or mouse anti-PSA-NCAM (1:250, Miltenyi
Biotec), mouse anti-TUJ1 (1:500, Covance), mouse anti-NeuN
(1:100, Millipore), mouse anti-GFAP (1:500, Millipore), rabbit
anti-Olig2 (1:500, Millipore), and anti-GLAST (ACSA-1) (1:500,
Miltenyi Biotec).
The sections were then washed in 0.1% Triton-PBS (PBT)
and incubated in blocking solution with the corresponding
secondary antibody for 1 h at room temperature (anti-
chicken Alexa 488, anti-mouse-IgG Alexa 488, anti-chicken
Alexa 647, anti-mouse-IgG or IgM Alexa 594, and anti-rabbit
Alexa 594, 1:400, Invitrogen). Hoechst was used for counter-
staining. Subsequently, the sections were washed, trans-
ferred to slides and air-dried. Immunofluorescence controls
consisted in omission of the primary antibodies. Fluores-
cence was detected using a confocal laser-scanning microscope
Leica TCS SP II (Leica, Wetzlar, Germany, http://www.leica-
microsystems.com/) equipped with an Ar and HeNe lasers.
Single z-stack sections were captured with sequential image
acquisition in order to avoid spectral cross-talk. For quantifica-
tion, one section each of 3 animals was randomly chosen for
each marker considered. Single z-stack sections were captured
over the complete graft area, and 500 GFP+ cells were counted.
For statistical analysis we used the Prism software and per-
formed two-tailed unpaired t-test, error bars represent the SD.Microarray analysis
1×106 cells were harvested, rapidly frozen in liquid nitrogen
and stored at −70 °C. Three biological replicates were
processed for each condition.CAM enriched precursors. (A, B) Gene expression fold change of
4 (A, differentiation day 16) and step 5 (B, differentiation day
nriched population at step 5 (annotations legend: light blue —
ission of nerve impulse; yellow — neuron projection). Biological
nd step 5 are shown.
138 S. Barral et al.RNA was isolated using standard RNA extraction pro-
tocols (Trizol). RNA quality and integrity were determined
using the Agilent RNA 6000 Nano Kit on the Agilent 2100
Bioanalyzer (Agilent Technologies, Böblingen, Deutschland,
http://www.home.agilent.com/agilent/home.jspx?cc=DE&lc=ger). RNA was quantified by measuring A260 nm on the ND-1000
Spectrophotometer (NanoDrop Technologies, Wilmington, DE,
USA, http://www.nanodrop.com/). Sample labeling and
hybridization was performed as detailed in the “Two-Color
Microarray-Based Gene Expression Analysis protocol” (Agilent).
Efficient neuronal differentiation after purification of mESC derived neuronal precursors 139Fluorescence signals of the hybridized Agilent Microarrays were
detected using Agilent's Microarray Scanner System G2505B
with a resolution of 5 μm. The Agilent Feature Extraction
Software (FES) version 10.7.3.1 was used to read out and
process the microarray image files. For determination of
differential gene expression, FES derived output data files
were further processed using the Rosetta Resolverâ gene
expression data analysis system (Rosetta Biosoftware).
All microarray data have been deposited in NCBI's Gene
Expression Omnibus7 and are accessible through GEO Series
accession number GSE35125 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?token=rzezjaoycqwcmtc&acc=GSE35125).
Differentially expressed genes were identified by a com-
bination of effect size and statistical significance based on
the Cy5 channel data. Only genes with an at least six-fold
upregulation in “step 5 enriched” samples compared to “step
5 control” samples and an unadjusted P-value (two-tailed
t-test, equal variance) of less than or equal to 0.05 were
subjected to annotation enrichment analysis using the
TreeRanker tool (Miltenyi Biotec). Term enrichment relative
to the expected background distribution was scored using
Fisher's exact test. Annotations were derived from publicly
available and literature-derived data sources, e.g. Gene
Ontology (GO, www.geneontology.org), signaling pathway
membership, sequence motifs, literature keywords, and
cell-specific marker genes.
ResultsImmunomagnetic enrichment of mESC-derived
PSA-NCAM+ neural precursors
In order to analyze PSA-NCAM expression during in vitro
neuronal differentiation of mESCs, we used a well-
established embryoid body (EB)-based five-step differen-
tiation protocol (Lee, et al., 2000), which recapitulates
early embryonic development (Fig. 1A). To facilitate
tracing of cells in transplantation studies, mESC derived
from actin-eGFP C57BL/6 transgenic mice (Hadjantonakis,
et al., 1998) (Fig. S1A) was used. Flow cytometry analysis
revealed that at the end of step 3 of the differentiation
protocol about 95% of the cells were e-GFP positive (Fig.
S1B). We evaluated PSA-NCAM expression at three time
points using flow cytometry (gating strategy is represented
in Figs. S2A–D). PSA-NCAM was already detectable at the
end of the differentiation step 3, after ITSFn selection for
neural precursors (Fig. 1B). Immunocystochemistry analysis
showed a predominant location of PSA-NCAM+ cells within
the cells exiting from the plated EB aggregates (Fig. 1C).
PSA-NCAM frequency increased at the end of step 4. In theFigure 4 In vivo characterization ofmESC derived neural precursors
Grafted GFP+ cells (green), immunopositive for PSA-NCAM (red) both
cells are integrated in the RMS and show typical surface PSA-NCAM sta
GFP (green) and TUJ1 (red) detected in the graft core and in the RMS b
images, insets, arrows, respectively). (E, G) Unsorted population, imm
GFAP (E) and Olig2 (G). (F, H) PSA-NCAM enriched population (green) e
unsorted and enriched population (I and J respectively, green) double
Scale bar=50 μm. Abbreviations: GFP, green fluorescent protein; PSA
fibrillary acidic protein; Olig2, oligodendrocyte transcription factor 2; R
marker.course of the final differentiation step, when withdrawal of
mitogen from medium cultivation triggers a post-mitotic
fate in the developing neuronal progenitors (4 days in step
5), the frequency of PSA-NCAM+ cells decreased (Fig. 1B).
To test whether an enrichment of mESCs derived
PSA-NCAM+ cells would increase neuronal differentiation,
we developed a protocol for isolation of the PSA-NCAM
positive fraction by magnetic cell sorting. The isolation
protocol was applied at step 3, the first time point when
PSA-NCAM expression was observed. Cells were harvested and
labeled with anti-PSA-NCAM–APC antibody followed
by anti-APC MicroBeads. Flow cytometric analysis showed an
initial frequency of 41.07±7.95% PSA-NCAM positive cells (Or.
Fr., Fig. 1D). Magnetic cell sorting enriched PSA-NCAM
positive cells to 92.65±1.86% (Pos. Fr., Fig. 1D) and did
not impede subsequent cultivation of sorted cells (Fig. 1E).
However, we observed that binding of the anti-PSA-NCAM
antibody and, therefore, sorting efficiency was impaired by
high levels of cellular debris (Fig. S3A). This was specifically
prominent when starting frequency of PSA-NCAM+ cells was
low (18.56±5.73%). For this reason we included an immu-
nomagnetic removal of dead cells prior to enrichment with
anti-PSA-NCAM. As shown in Fig. S3B, this eventually allowed
us to achieve a high purity (93.52±0.96%) of PSA-NCAM+ cells.
PSA-NCAM is not exclusively expressed in CNS. For instance,
βhigh- and βlow-pancreatic cells have been characterized
based on differential PSA-NCAM expression (Karaca et al.,
2009). In order to investigate the potential contamination of
pancreatic endocrine cells among the PSA-NCAM+ cells, we
analyzed the gene expression profile of the PSA-NCAM positive
fraction using whole genome micro array. We then queried for
pancreas-associated genes based on Gene Ontology annota-
tion and found that 34 pancreas-associated genes, were
upregulated in the PSA-NCAM positive fraction as compared
to undifferentiated mESC. However it is well-known that all
this 34 genes are also expressed in neural development as
FoxA2, NeuroD1, Pax6, Sox9, Isl1 and Nkx6.1. Pancreatic
endocrine cells share a high number of expressed genes with
neurons and pancreatic development is driven by many
transcription factors which are described in neural develop-
ment. Genes expressed in neural precursors were upregulated
in the PSA-NCAM positive fraction as Dcx, Sox1, Robo2, TUBB3,
and Ascl1 (Fig. S4A). We then searched for the expression of
genes known to be involved in pancreatic islet development
and maintenance as Sox17, Pdx1, Hlxb9, Pax4, Ptf1a, Hnf4,
Hnf6, and Gata4. Except for Hnf6 that appears 3 fold
downregulated, not one of the other genes was found. Finally
we analyzed by immunofluorescence the presence of Sox17, a
well known marker for definitive endoderm. While we were
able to detect few positive cells at the end of the differ-
entiation step 3 (before PSA-NCAM enrichment) (Fig. S4B),and PSA-NCAM enriched progenitors after 10 days post graft. (A, B)
in the unsorted (A) and PSA-NCAM enriched population (B). GFP+
ining (see insets, arrows). (C–D) Double immunopositive cells for
oth in unsorted and PSA-NCAM enriched population (left and right
unohistochemistry for GFP (green) and co-expression (red) with
xpressing GFAP (F, red) and Olig2 (H, red). (I, J) Grafted cells from
positive with nestin (blue). Arrows in insets: double positive cells.
-NCAM, polysialylated neural cell adhesion molecule; GFAP glial
MS, rostral migratory stream. 3–4 animals were analyzed for each
140 S. Barral et al.after 24 h plating, only few Sox17+ positive cells were found in
the PSA-NCAM negative, and no immunopositive cells were
detected in the PSA-NCAM positive fraction (Fig. S4C).In vitro differentiation of mESC derived PSA-NCAM+
precursors
In order to evaluate the lineage propensity of PSA-NCAM+
cell fraction, sorted cells were further differentiated
following the above mentioned protocol. After neural
progenitor expansion (step 4), the PSA-NCAM enriched popu-
lation gave rise to a significantly higher number of nestin
and PSA-NCAM expressing cells as compared to the unsorted
control population with 75.75±7.48% vs. 54.08±5.34%
nestin+ cells and 50.69±1.74% vs. 23.24±4.23% PSA-NCAM+
cells, respectively (Figs. 2A, B, E, F, S). This indicated
that the ES cell derived PSA-NCAM sorted cells were indeed
enriched for neural precursors. To further assess the differ-
ences in the differentiation of cells after PSA-NCAM enrich-
ment, we stained for Ki-67 and Oct4 expression. We
observed a slight though statistically not significant reduced
number of proliferating Ki-67 positive cells in the PSA-NCAM
enriched cell population (Fig. 2S; 44.11±16.53% vs. 29.14±
16.17% Ki-67+ cells for unsorted vs. enriched cells). The
number of residual Oct4 positive cells was strongly reduced
in the PSA-NCAM enriched population (b10 cells per 24 well
plate; Figs. 2C, G, S), indicating highly efficient removal of
potentially teratoma-forming pluripotent stem cells. After
neuronal differentiation (step 5), the PSA-NCAM enriched
population gave rise to a significantly increased number
of cells with neuronal characteristics as indicated by the
expression of the early post-mitotic marker TUJ1or the later
expressed neuronal proteins, MAP2 and GAD67 (Figs. 2I–K,
N–P, T; 29.98±3.02% vs. 45.69±6.64% TUJ1+ cells, 21.87±
3.47% vs. 48.13±2.21% MAP2+ cells and 18.37±2.67% vs.
31.65±2.45% GAD67+ cells for unsorted vs. enriched cells).
Some cells also expressed NeuN (Fig. S5A), while only few
cells were TH+ (data not show). Notably, in both the
unsorted and PSA-NCAM enriched population, we were able
to detect expression of synaptophysin, a marker for vesicular
synapses (Fig. S5B).
In contrast, the number of GFAP or Olig2 positive glial
cells was similar in the control and the PSA-NCAM enriched
population (Figs. 2L, M, Q, R, T; 29.26±1.38% vs. 27.97±
1.22% GFAP+ cells and 11.71±2.39% vs. 14.86±3.25% Olig2+).
To further delineate the differences between the
PSA-NCAM enriched and control cells, we analyzed the
gene expression of both populations at steps 4 and 5 of
differentiation using whole genome arrays. Differentially
expressed genes were first grouped according to their
functional annotation. Already at differentiation step 4,
the PSA-NCAM enriched population showed a higher presen-
tation of genes involved in neuron development (e.g. Sox6
and Gsk3b), and more specific, genes included in synaptic
transmission (e.g. Syn2 and Synpr), neuron differentiation,
axogenesis (e.g. Dcc, Robo2, and Ncam2), and regulation
of neurotransmitter levels (e.g. Cnr1 and Gria3) (Fig. 3A). A
smaller proportion of the differentially expressed genes
was reduced in the enriched population and most of them
mapped to biological terms related to pluripotency and
development (e.g. Pou5f1, Nodal, and Lin28a) of non-neuronal lineages (e.g. Myh6, Myl7, Myo1f, Myo1g, Lin28a,
and Hnf1a) (Fig. 3A). The enrichment of genes involved in
neuronal development, detected in the PSA-NCAM+ fraction
at step 4 became more prominent at the end of neuronal
differentiation. Here, the gene expression profile showed
up-regulation of genes exclusively involved in neural, and
particularly neuronal, activity (Fig. 3C). For example, we
found enrichment of biological terms such as synapse (repre-
sentative genes: Pcdh11, Syn2, and Pclo), nervous system
development (representative genes: Dcx, Map2, and St8sia4),
transmission of nerve impulse (representative genes: Gabra2
and Gria1), neuron projection, ion channel complex, ion
transmembrane transporter, voltage gated cation channel
activity (representative genes: Cacng2, Kcnd2, and Scn2a1),
regulation of action potential, glutamate signaling pathway
(represented here by the gene V-Glut), and GABA receptor
activity (represented here by the gene Gabra2) (Fig. 3B).
Genes involved in pluripotency, like Pou5f1 (Oct4) and Nodal,
were still present in the PSA-NCAM enriched population at low
levels (Fig. 3B). Moreover, we found an under-representation
of biological terms related to development (representative
genes: Eomes and Foxd3) and proliferation (representative
genes: Ccnb1ip1, C79407, and Cdc6).PSA-NCAM enriched neural precursors survive
in vivo and differentiate into neurons.
We next compared the in vivo differentiation potential of
unsorted and enriched PSA-NCAM+ cells. Actin-GFP C57BL/6
mESCs were differentiated and purified using PSA-NCAM
immunoreactivity as described above (Immunomagnetic
enrichment of mESC-derived PSA-NCAM+ neural precursors
section). The unsorted and the PSA-NCAM positive popu-
lations were stereotactically injected into the forebrain of
adult mice. After 10 days post graft (dpg), grafted cells were
distributed between layer 1 of the somatomotor cortex and
the more ventral curve of the RMS (dorsal–ventral axis), and
between the orbital areas rostrally and the fiber tract,
caudatoputamen and lateral ventricle caudally. The pheno-
type and differentiation of grafted cells were analyzed at 10
or 40 dpg. Double staining for transgenic-GFP, and several
markers for neuronal (PSA-NCAM, TUJ1, NeuN, and MAP2),
glial (GFAP, GLAST, and Olig2), or neural stem cells (nestin)
was performed.
Ten days post-grafting, PSA-NCAM enriched cells showed
a high level of PSA-NCAM and TUJ1-immunoreactivity within
the graft area as shown by quantification of the immuno-
fluorescence (Fig. S6A; GFP+/PSA-NCAM+ 29.51±8.96% and
GFP+/TUJ1+ 40.2±2.75%). PSA-NCAM and TUJ1 positive cells
were found mainly in the central area of the graft, where they
tended to reside in clusters. In addition, some GFP+/PSA-
NCAM+ or GFP+/TUJ1+ cells were also found in the rostral
migratory stream (RMS), a structure that contains high
numbers of PSA-NCAM/TUJ1 positive migratory neuroblasts
in the adult (Bonfanti and Theodosis, 1994) (Figs. 4B, D).
In contrast, only few cells in the unsorted population were
GFP+/PSA-NCAM+ or GFP+/TUJ1+. Notably, only few GFP+/
TUJ1+ cells were located in the graft area (Fig. S6A 7.49±
3.88%), while most resided in the RMS (Fig. 4C). GFP+/
PSA-NCAM+ cells were located in the RMS and not in the graft
Efficient neuronal differentiation after purification of mESC derived neuronal precursors 141area (Fig. 4A). Next, we analyzed the expression of astro-
cyte markers GFAP and GLAST and the oligodendrocyte
marker Olig2 (Figs. 4E–H). We found all three markers on
grafted cells derived from the PSA-NCAM enriched as well
as the control population (Fig. S6A 11.95±5.59% vs. 9.22±
6.04% GFAP+ cells and 6.71±4.81% vs. 11.46±3.24% Olig2+
cells for unsorted vs. enriched cells). Notably, Olig2 posi-
tive cells were located within as well as outside the graft
area, indicating migration of these cells into the host
tissue, which contrasts the behavior of GFP+/GFAP+ that
were always retained in the graft area. We also observed
an intense GFAP and GLAST staining around the graft mass,
which did not co-localize with GFP probably related to a
host gliosis reaction. The neural stem cell marker nestin
was detected in both populations (Figs. 4I, J) even if in
the PSA-NCAM enriched population the GFP+/nestin+ cells
were significantly lower than in the unsorted population
(Fig. S6A 11.46±4.2% vs. 1.82±2.28% nestin+ cells for unsorted
vs. enriched cells). Interesting, considering the glial markers
(GFAP and Olig2) and neuronal marker (TUJ1) we found that
after 10 dpg only a small portion of the cells in the unsorted
population were neural and mainly of glial lineage, while
in the PSA-NCAM enriched population more than the 60% were
neural with predominance of TUJ1+ cells (Fig. S6B). Impor-
tantly, we were not able to detect GFP positive cells that
expressed the mature neuronal marker NeuN in both, the
PSA-NCAM enriched and the unsorted population.
However, forty days post grafting the PSA-NCAM enriched
as well as the not enriched control population showed
expression of NeuN (Figs. 5A, K). At this time point, grafted
cells were distributed throughout all neuronal layers of the
frontal cortex. Notably, while in the unsorted population a
relatively small number of the cells were GFP+/NeuN+ (14.1±
7.6%), a much higher number of cells in the PSA-NCAM
enriched population showed NeuN-immunoreactivity (69.1±
6.5%) (Fig. 5b). In line with this observation, unsorted
ES derived GFP+ cells were still PSA-NCAM or TUJ1-
immunoreactive (Figs. 5B–G), while no GFP/PSA-NCAM double
positive cells and only few GFP/TUJ1 double positive cells
were detected in the PSA-NCAM enriched population
(Figs. 5L–R). The percentage of cells immunoreactive for the
glial markers GLAST, GFAP, or Olig2 was comparable in both
grafted populations (Figs. 5H–J, S–a).
Importantly, in case of control cell grafting, 7 out of 15
animals showed a severe damage of the host neural tissue at
10 dpg. In particular, in these animals the tissue surrounding
the injection site, covering half of the frontal hemisphere,
came off in a single block during dissection. In the remaining
animals the volume of the graft was comparable to animals
where PSA-NCAM enriched population was grafted (0.107±
0.045 mm3 vs.0.079±0.047 mm3, mean±SD n=3 mice;
Figs. S7A–D). Between 10 and 40 dpg, 3 animals died and at
40 dpg, we detected an extensive cellular overgrowth in 4 of
the animals where control cells were transplanted. None of
the 15 animals where PSA-NCAM enriched cells were trans-
planted showed damage of the neural tissue at 10 dpg and
only one animal died between 10 and 40 dpg. Rosettes like
structures indicating tumor formation were observed in only 1
animal at 40 dpg.
Cells immunopositive for the cell cycle marker Ki67+ were
detected in both unsorted and PSA-NCAM enriched popula-
tions at 10 dpg (Figs. S7E, F).Migration of PSA-NCAM in vitro derived neural
precursors.
We demonstrated in a previous study that after homotypic
transplantation of SVZ tissue from actin-EGFP transgenic
adult donor mice, graft-derived cells underwent migration
and differentiation indistinguishable from endogenous pre-
cursors (Seidenfaden, et al., 2006). Neuroblasts, character-
ized by a leading and a trailing process and the expression of
TUJ1, doublecortin and PSA-NCAM (Bonfanti and Theodosis,
1994), migrate along the RMS towards the olfactory bulb
(Rousselot, et al., 1995), where they further differentiate
into mature NeuN+ neurons. We evaluated whether ES derived
in vitro generated neural cells have the same ability tomigrate
and differentiate along the RMS and whether this behavior is
influenced by PSA-NCAM enrichment of in vitro differentiating
cells. To this end, GFP+ unsorted and PSA-NCAM enriched cells
were transplanted in the RMS of adult mice at a long distance
(around 4 mm) from the lateral ventricle, in order to reduce
the influence of the SVZ neurogenic niche (Figs. 6A, H).
Ten days post grafting some GFP+ cells entered the RMS,
displayed the typical elongated morphology of migrating
neuroblasts and were positive for PSA-NCAM and TUJ1
(Figs. 6F, 4A–D). Cells enriched for PSA-NCAM prior to
grafting migrated to a much higher percentage (73.5%±9.1)
along the RMS as compared to the unsorted control cells
(5.6%±4.5) (Fig. 6B). We collected sequential confocal
single z-stack images covering the area from the graft
point at the RMS level to the OB and measured the migration
distance of each GFP+ cell (Fig. 6C). Cells from the unsorted
population remained close to the area of the graft, mostly at
a distance below 240 mm and exhibited projecting thick
filaments along the RMS (Figs. 6A, D, E). In contrast, most of
the PSA-NCAM enriched cells that entered the RMS were
distributed over 500 mm from the graft area with some cells
reaching the OB and starting to migrate radially towards
the glomerular cell layer (Figs. 6F–H). However, we did not
observe cells integrated in the granule cell layer or in the
glomerular layer of the OB.
A different situation was observed after 40 days post
grafting. At this time point the RMS was always devoid of
grafted cells with migratory morphology, both in the unsorted
and PSA-NCAM enriched population. Grafted cells that were
still present in the RMS, had a more differentiated morphol-
ogy, characterized by long and branched projections. At
this time point GFP+ cells were undetectable in the central
OB and the different neuronal layers.Discussion
Pluripotent stem cells (PSCs) like ESCs or induced pluripo-
tent stem cells (iPSCs) are an attractive source for cell
replacement therapy. They can be expanded and differenti-
ated in virtually any cell type. Several studies have demon-
strated the production of neuronal (Friling, et al., 2009; Lee,
et al., 2000; Okabe, et al., 1996; Wichterle, et al., 2002) and
glial (Brustle et al., 1999; Liu et al., 2000) lineage phenotypes
from ESCs by using various techniques. Despite advances in
development of different neural induction conditions for
mESCs or hESCs, protocols end generally in mixed populations
containing neural cells at different development stages,
Figure 5 In vivo maturation of PSA-NCAM-enriched versus unsorted mESC derived neural precursors. (A–J) Immunofluorescence
analysis of the unsorted population at 40 days post graft. Double positive cells for GFP (green), NeuN (A, red), PSA-NCAM (B–D, red),
TUJ1 (E–G, red), and GFAP (H–J, red). (K–a) Immunofluorescence analysis of the PSA-NCAM enriched population (GFP+, green) at 40 days
post graft. Graft core area positive for NeuN (K, red). No GPF/PSA-NCAM (red) double-immunopositive cells are detected (L–N).
Double-immunopositive cells for GFP (green), TUJ1 (P–Q, red), GFAP (S–U), and Olig2 (V–X, red). No cells are found double positive for
GFP and nestin (Y–a, blue). (b) Quantification of the data presented in A, K; mean±S.E.M., n=3 (mice): **Pb0.01. Scale bar=50 μm.
Abbreviations: GFP, green fluorescent protein; PSA-NCAM, polysialylated neural cell adhesion molecule; GFAP glial fibrillary acidic
protein; Olig2, oligodendrocyte transcription factor 2; ctx, cortex. For each marker 3–4 animals were analyzed.
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Figure 6 Migration of PSA-NCAM in vitro derived neural precursors. (A, H) High resolution image reconstructions covering the area
from the graft point at the RMS level to the OB. Double staining for GFP (green) and PSA-NCAM (red). White bars represent the starting
point for measurement of the distance length. (B) Quantification of the GFP+ cells from graft level to OB; mean±S.E.M., n=3 (mice):
**Pb0.01. (C) Migration distance covered by grafted cells in two representative animals. (D, E) Insets in A (left and right respectively)
showing only few cells (arrow) and fiber extensions (asterisk) GFP+/PSA-NCAM+ in RMS. (F, G) Insets in H, left and right respectively,
showing GFP+ cells with elongated morphology integrated in the RMS host structure (F, arrows) and GFP+ cells at the entrance of OB.
Scale bar=200 μm (A, H); 20 μm (D–G). Abbreviations: GFP, green fluorescent protein; PSA-NCAM, polysialylated neural cell adhesion
molecule; RMS, rostral migratory stream; OB olfactory bulb.
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use of flow cytometry ormagnetic sorting techniques based on
specific neural cell surface markers has been suggested to
improve in vitro differentiation protocols by simply enriching
desired cell or depleting unwanted ones (Bosio, et al., 2009;
Pruszak, et al., 2007). In view of a translational approach
where eventually a clinical grade, gentle and fast isolation of
cells needs to be performed we decided to choose magnetic
cell sorting (MACS) as the sorting technology (Bosio, et al.,
2009). Most of the sorting strategies applied until now
required transgenic techniques (Hedlund et al., 2007, 2008;
Xian, et al., 2003) or the combination of two or more different
surface markers (Cremer, et al., 1998; Pruszak, et al., 2009,
2007; Yuan, et al., 2011). We decided to develop a simple
strategy for purification of neuronal precursors based on a
single precursor marker. The choice of the neural subpopula-
tion to be enriched has proved challenging. Previous studies
on human ESCs reported that despite enrichment of specific
subpopulations of neurons, grafts exhibited expanding clusters
of undifferentiatedmitotic neuroepithelial cells, which can be
tumorigenic (Roy, et al., 2006). Moreover, cells too advanced
in their differentiation failed to survive in the host tissue,
showing poor engraftment by evidence of inflammation and
dead cells (MacLaren, et al., 2006). We focused our attention
on a specific subpopulation of neural precursors that is
characterized by the expression of the extracellular PSA
modification. During embryonic development virtually all the
futuremature neurons express PSA-NCAM and previous studies
demonstrated that neural precursors derived from NTera2cells and enriched for PSA-NCAM were able to further
differentiate in specific subpopulation in vitro (Schwartz
et al., 2005). In our study we demonstrated that PSA-NCAM
was also differentially expressed during in vitro differen-
tiation of mESCs and developed a protocol for magnetic
enrichment of ES derived PSA-NCAM+ cells. PSA-NCAM in vitro
derived positive cells were found to have neural feature based
on the upregulation of several genes involved in neuronal
development and characteristic of neural precursors. More-
over, following in vitro neuronal differentiation, PSA-NCAM+
cells efficiently generated neurons as demonstrated by the
increased number of TUJ1, MAP2 and GAD67 positive cells and
the up-regulation of several neuronal genes compared to
control cells where no enrichment was applied. Enrichment
for PSA-NCAM not only increased the neuronal differentiation
potential of the protocol applied here, but also robustly
removed teratoma-forming pluripotent stem cells as demon-
strated both by the dramatic decrease of Oct4 positive cells
and the down-regulation of genes involved in maintenance of
pluripotency. However, according to staining with the cell
cycle marker Ki67, no significant reduction of proliferative
cells was detected after differentiation of the PSA-NCAM-
enriched neural precursors. Our observation of proliferative
cells derived from PSA-NCAM enriched cells can either be
explained by contaminants or by the point that PSA-NCAM+
cells themselves can be proliferative. Given the high degree of
purity we achieved we favor the hypothesis that the ES
derived PSA-NCAM+ cells have a rather embryonic, prolifera-
tive phenotype.
144 S. Barral et al.Beyond the finding that PSA-NCAM enrichment could be
useful to improve the in vitro neuronal differentiation pro-
tocol, we also addressed the question whether PSA-NCAM-
expressing neural progenitors are a potential source for cell
replacement therapies. In a previous study, enrichment of
PSA-NCAM+-precursors was applied previous transplantation
with unsatisfactory results due to a low number of surviving
neurons (Friling, et al., 2009). Here we demonstrate that
magnetically enriched PSA-NCAM+ precursors not only survived
well in the host tissue, but also increased the number of
mature neurons in vivo. Moreover, PSA-NCAM+-ES cell-derived
precursors did not fail to migrate when grafted in a responsive
anatomical area like the RMS. The influence of the PSA
modification on the migration of cells in embryonic and adult
neurogenic areas has been known for a while (for review see
Bonfanti, 2006; Durbec and Cremer, 2001). Overexpression of
PSA-NCAM in ES cell-derived glial precursors strikingly modi-
fied their migration behavior in response to guidance cues as
demonstrated by chemotaxis assays and in vivo studies (Glaser
et al., 2007). We demonstrate here that mESC derived cells
endogenously expressing PSA-NCAM respond to in vivo cues.
Tabar et al. reported that human ES cell derived neural
precursors that where grafted in the SVZ and displayed the
ability to migrate and to further differentiate (Tabar et al.,
2005). However, when cells are grafted into the SVZ their
further behavior might be imposed by the strong neurogenic
environment and does not directly reflect their intrinsic
program. Therefore, in our study, to better assess migration
and differentiation ability, PSA-NCAM+ cells where grafted
directly in the RMS, distant to the SVZ niche. Thismight explain
why in our study cells failed to become GABAergic and
dopaminergic interneurons in the granular and glomerular
layers of the OB.
The origin of the glial cells seen both in vitro and in vivo
needs to be analyzed further. The Olig2 and GFAP-
immunopositive cells might develop from contaminants
present in the positive fraction after sorting and increase
their frequency in the final population due to their higher
proliferation rate. On the other hand, glial cells might
differentiate from the PSA-NCAM expressing cells. Indeed,
unlike its prevalent distribution in cells of the neuronal lineage
within the mature nervous tissue, PSA-NCAM is also associated
with glial precursors during development (for review see
Bonfanti, 2006). For example, a previous study demonstrated
in vitro that among PSA-NCAM+ cells isolated from neonatal
brain were oligondendrocyte pre-progenitors, corresponding
to early precursors of the oligondendrocyte-type2 astrocyte
(O-2A) lineage (Ben-Hur, et al., 1998). Moreover, PSA-NCAM+
cell precursors used for transplantation in a focal demyelin-
ating lesion were found to produce remyelinating Schwann
cells in the CNS (Keirstead et al., 1999).
It remains to be investigated if enrichment for PSA-NCAM
expressing neural precursors from ES derived cells could also
help to better restore lost function in animal disease models
and whether the findings with mouse cells can be translated
to human cells. Good promises in this direction come from a
recent study where PSA-NCAM enrichment was applied to
improve purity during in vitro neural differentiation protocol
of hESCs (Mak et al., 2012). Furthermore, the tumorigenic
potential of the enriched population has to be addressed
in greater detail. Here we show promising results based on
a decreased number of Oct4 expressing cells and missingabnormal cell growth in the in vivo studies. However, it
has to be noticed that an extended proliferation level was
observed both in vitro and in vivo after short time points
post sorting albeit not after 40 days. Therefore, we cannot
exclude the risk of tumor formation, especially after longer
time periods than studied here.
In summary, PSA-NCAM based-lineage selection permits
efficient enrichment of young ES cell-derived neuronal pre-
cursors, relying on a single endogenous marker and avoiding
genetic modification. If this general strategy can be translated
to human cells it might represent a preferred strategy for
exploring future therapeutic applications.
Supplementary data to this article can be found online at
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